| Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy T Puthanakit, L Aurpibul, P Oberdorfer, N Akarathum, S Kanjananit, ... Clinical Infectious Diseases 44 (4), 599-604, 2007 | 183 | 2007 |
| Isoniazid preventive therapy in HIV-infected pregnant and postpartum women A Gupta, G Montepiedra, L Aaron, G Theron, K McCarthy, S Bradford, ... New England Journal of Medicine 381 (14), 1333-1346, 2019 | 127 | 2019 |
| Neurodevelopmental outcomes in HIV-exposed-uninfected children versus those not exposed to HIV SJ Kerr, T Puthanakit, U Vibol, L Aurpibul, S Vonthanak, P Kosalaraksa, ... AIDS care 26 (11), 1327-1335, 2014 | 120 | 2014 |
| Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration V Leroy, K Malateste, H Rabie, P Lumbiganon, S Ayaya, F Dicko, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (2), 208-219, 2013 | 107 | 2013 |
| Poor cognitive functioning of school-aged children in Thailand with perinatally acquired HIV infection taking antiretroviral therapy T Puthanakit, L Aurpibul, O Louthrenoo, P Tapanya, R Nadsasarn, ... AIDS patient care and STDs 24 (3), 141-146, 2010 | 98 | 2010 |
| Lipodystrophy and metabolic changes in HIV-infected children on non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy L Aurpibul, T Puthanakit, B Lee, A Mangklabruks, T Sirisanthana, ... Antiviral therapy 12 (8), 1247-1254, 2007 | 98 | 2007 |
| Response to measles, mumps, and rubella revaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy L Aurpibul, T Puthanakit, T Sirisanthana, V Sirisanthana Clinical infectious diseases 45 (5), 637-642, 2007 | 77 | 2007 |
| Survival of HIV-infected children: a cohort study from the Asia-Pacific region P Lumbiganon, A Kariminia, L Aurpibul, R Hansudewechakul, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 56 (4), 365-371, 2011 | 57 | 2011 |
| Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand T Puthanakit, L Aurpibul, P Oberdorfer, N Akarathum, S Kanjanavanit, ... The Pediatric infectious disease journal 26 (10), 953-956, 2007 | 57 | 2007 |
| Antibody response to hepatitis B re-vaccination in HIV-infected children with immune recovery on highly active antiretroviral therapy M Lao-Araya, T Puthanakit, L Aurpibul, T Sirisanthana, V Sirisanthana Vaccine 25 (29), 5324-5329, 2007 | 56 | 2007 |
| Plasma efavirenz concentrations and the association with CYP2B6-516 G >T polymorphism in HIV-infected Thai children T Puthanakit, P Tanpaiboon, L Aurpibul, TR Cressey, V Sirisanthana Antiviral therapy 14 (3), 315-320, 2009 | 52 | 2009 |
| Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children IMPAACT P1069 Team, K Chokephaibulkit, TR Cressey, E Capparelli, ... Antiviral therapy 16 (8), 1287-1295, 2011 | 48 | 2011 |
| Pharmacological assessment of efavirenz weight-band dosing recommendations in HIV-infected Thai children TR Cressey, L Aurpibul, T Narkbunnam, V Sirisanthana, W Phongsamart, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 62 (1), e27-e29, 2013 | 44 | 2013 |
| Brain imaging and neurodevelopment in HIV-uninfected Thai children born to HIV-infected mothers N Jahanshad, MC Couture, W Prasitsuebsai, TM Nir, L Aurpibul, ... The Pediatric infectious disease journal 34 (9), e211-e216, 2015 | 43 | 2015 |
| Prevalence of protective antibody against measles in HIV‐infected children with immune recovery after highly active antiretroviral therapy L Aurpibul, T Puthanakit, S Siriaksorn, T Sirisanthana, V Sirisanthana HIV medicine 7 (7), 467-470, 2006 | 39 | 2006 |
| Review of tenofovir use in HIV-infected children L Aurpibul, T Puthanakit The Pediatric infectious disease journal 34 (4), 383-391, 2015 | 36 | 2015 |
| Haematological changes after switching from stavudine to zidovudine in HIV‐infected children receiving highly active antiretroviral therapy L Aurpibul, T Puthanakit, T Sirisanthana, V Sirisanthana HIV medicine 9 (5), 317-321, 2008 | 35 | 2008 |
| Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy L Aurpibul, T Puthanakit, T Sirisanthana, V Sirisanthana Clinical infectious diseases 50 (10), 1415-1418, 2010 | 33 | 2010 |
| Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing L Aurpibul, TR Cressey, S Sricharoenchai, O Wittawatmongkol, ... The Pediatric infectious disease journal 34 (4), 392-397, 2015 | 32 | 2015 |
| Reversal of growth failure in HIV-infected Thai children treated with non-nucleoside reverse transcriptase inhibitor–based antiretroviral therapy L Aurpibul, T Puthanakit, S Taecharoenkul, T Sirisanthana, V Sirisanthana AIDS patient care and STDs 23 (12), 1067-1071, 2009 | 31 | 2009 |
